Evidence map›Paper›PMID 36463189›Full record

ArticleHarm reduction journal2022

Prevalence and correlates of using opioids alone among individuals in a residential treatment program in Michigan: implications for overdose mortality prevention.

Rachel E Gicquelais, Becky L Genberg, Jessica L Maksut, Amy S B Bohnert, Anne C Fernandez

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rachel E GicquelaisSchool of Nursing, University of Wisconsin-Madison, 4257 Signe Skott Cooper Hall, 701 Highland Avenue, Madison, WI, 53705, USA. gicquelais@wisc.edu.
Becky L GenbergDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD, 21205, USA.
Jessica L MaksutDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD, 21205, USA.
Amy S B BohnertDepartment of Anesthesiology, University of Michigan, 2800 Plymouth Rd, Ann Arbor, MI, 48109, USA.
Anne C FernandezDepartment of Psychiatry, University of Michigan, 2800 Plymouth Rd, Ann Arbor, MI, 48109, USA.
Johns Hopkins University · USUniversity of Michigan–Ann Arbor · USUniversity of Wisconsin–Madison · US

Funding

Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
Integrating Alcohol Screening, Brief Intervention, and Referral to Treatment into Presurgical CareK23AA023869 · NIAAA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FERNANDEZ, ANNE CHRISTIE · 2016 to 2020
$857k
Developing a Prescription Opioid Overdose Prevention InterventionR34DA035331 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOHNERT, AMY S B · 2014 to 2016
$672k
NIAAA NIH HHS K23 AA023869NIAID NIH HHS T32 AI102623NIDA NIH HHS R34 DA035331
6 · The paper itself

Abstract

backgroundAvoiding use of opioids while alone reduces overdose fatality risk; however, drug use-related stigma may be a barrier to consistently using opioids in the presence of others.

methodsWe described the frequency of using opioids while alone among 241 people reporting daily heroin use or non-prescribed use of opioid analgesic medications (OAMs) in the month before attending a substance use disorder treatment program in the Midwestern USA. We investigated drug use-related stigma as a correlate of using opioids while alone frequently (very often vs. less frequently or never) and examined overdose risk behaviors associated with using opioids while alone frequently, adjusted for sociodemographic and clinical characteristics.

resultsThe sample was a median age of 30 years, 34% female, 79% white, and nearly all (91%) had experienced an overdose. Approximately 63% had used OAMs and 70% used heroin while alone very often in the month before treatment. High levels of anticipated stigma were associated with using either opioid while alone very often (adjusted PR: 1.20, 95% CI: 1.04-1.38). Drinking alcohol and taking sedatives within two hours of OAMs very often (vs. less often or never) and using OAMs in a new setting very often (vs. less often or never) were associated with using OAMs while alone very often. Taking sedatives within two hours of using heroin and using heroin in a new setting very often (vs. less often or never) were associated with using heroin while alone very often.

conclusionAnticipated stigma, polysubstance use, and use in a new setting were associated with using opioids while alone. These findings highlight a need for enhanced overdose harm reduction options, such as overdose detection services that can initiate an overdose response if needed. Addressing stigmatizing behaviors in communities may reduce anticipated stigma and support engagement and trust in these services.

Indexed as

Analgesics, OpioidDrug OverdoseAdultFemaleHeroinHumansHypnotics and SedativesMaleMichiganPrevalenceResidential TreatmentAnalgesics, OpioidHeroinHypnotics and SedativesHarm reductionOpioidsOverdosePolysubstance useStigmaUsing alone

Identifiers

PMID36463189
PMCPMC9719663
OpenAlexW4310783209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.